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Serum metabolite markers of early 
Mycoplasma hyopneumoniae infection in pigs
Meera Surendran Nair1, Dan Yao2, Chi Chen2 and Maria Pieters1* 
Abstract 
Mycoplasma hyopneumoniae, the primary pathogenic bacterium causing enzootic pneumonia, significantly affects 
worldwide swine production. The infection is usually persistent and bacterial identification and isolation of M. hyo-
pneumoniae in clinical samples are challenging due to the fastidious requirements for its growth. Hence, new practical 
surveillance tools that improve or complement existing diagnostics on M. hyopneumoniae are desirable, especially 
in early infection. The objective of this study was to identify potential metabolite markers of early M. hyopneumo-
niae infection in pigs through metabolomics analysis. Samples obtained from pigs in a previous M. hyopneumoniae 
experimental infection were used in this study. Briefly, two pigs served as mock inoculated controls and ten pigs were 
intra-tracheally inoculated with M. hyopneumoniae. Sera, laryngeal swabs (LS), and tracheo-bronchial lavage fluid 
(TBLF) were collected from all pigs at 0, 2, 5, 9, 14, 21 and 28 days post-inoculation (dpi). Bronchial swabs (BS) were 
collected post-mortem at 28 dpi. Mycoplasma hyopneumoniae infection was confirmed by PCR in LS, TBLF and BS. 
Serum metabolites were profiled using high-resolution liquid chromatography–mass spectrometry (LC–MS) analysis. 
Metabolite markers were identified by structural analysis following multivariate analysis of LC–MS data. The results 
showed that M. hyopneumoniae infection time-dependently altered the serum levels of selective amino acids and 
fatty acids. α-Aminobutyric acid and long-chain fatty acids were markedly increased at 14 and 21 dpi in inoculated 
pigs (p < 0.05). These results indicated that M. hyopneumoniae infection caused systemic changes in host metabolism, 
warranting further studies to determine underlying biochemical and physiological mechanisms responsible for the 
observed changes.
© The Author(s) 2019. This article is distributed under the terms of the Creative Commons Attribution 4.0 International License 
(http://creat iveco mmons .org/licen ses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, 
provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, 
and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/
publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.
Introduction
Mycoplasma hyopneumoniae (M. hyopneumoniae) is a 
major health risk in the porcine industry, causing enzo-
otic pneumonia (EP), a chronic respiratory disease in 
growing pigs. Enzootic pneumoniae is often chronic, 
with a pattern of slow spreading and progression over 
the course of months, which usually results in herd mor-
bidities that can reach up to 70–100% [1–3]. Coughing, 
poor weight gain, and reduced feed conversion are typi-
cal signs of infected pigs [1]. The incubation period of M. 
hyopneumoniae is difficult to predict under natural con-
ditions as it may depend on the infectious dose, immune 
status of pigs, and presence of associated secondary 
respiratory infections [4]. However, in clinically affected 
herds, seroconversion and coughing have been reported 
to appear 2–6  weeks post-infection [5], varying across 
production systems. The prevalence of M. hyopneumo-
niae is often reported highest in growing-finishing pigs, 
although clinical disease or pathogen detection can also 
occur early in nursery pigs and in breed-to-wean farms 
[6, 7].
Chronicity is a prominent characteristic of mycoplasma 
infections. The ability of the bacteria to escape detection 
by adaptive immune surveillance mechanisms is associ-
ated with the challenges in early detection and preven-
tion [8]. In swine production, extended shedding and 
prolonged transmissibility of M. hyopneumoniae to naïve 
contact pigs has been documented up to 214 days post-
infection (dpi) [9]. Because of low mortality associated 
with EP, post-mortem lung lesions are usually observed 
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in slaughtered pigs or when losses occur due to superim-
posed secondary infections [10].
The fastidious growth requirements pose challenges for 
bacterial culture and isolation of M. hyopneumoniae from 
clinical samples. At present, serological assays targeting 
antibodies against M. hyopneumoniae are most com-
monly used to detect exposure [11]. While advantageous 
in cost and convenience, these assays have limitations, 
including low sensitivity to detect early or subclinical 
infection, potential antigenic cross-reactivity with other 
respiratory commensal mycoplasmas, and lack of dis-
crimination between infected and vaccinated pigs, which 
count for more than 70% of pig herds globally [2]. Com-
pared to serodiagnosis, PCR assays offer higher degree of 
accuracy in detecting the genomic DNA of M. hyopneu-
moniae [12] from clinical samples [13, 14]. However, the 
consistency of PCR detection across different sample 
types varies [13] and many sampling methods are con-
sidered invasive in live animals. All these situations make 
the diagnosis of M. hyopneumoniae infections extremely 
challenging.
Metabolomics has been utilized to identify dormant 
and intricate interactions between hosts and pathogens 
[15, 16]. Metabolic events that occur during host–patho-
gen interactions reflect how the host responds to patho-
gens and also how a pathogen adapts and proliferates in 
its host environment [15]. Applications of metabolomics 
in studying infectious diseases in humans and animals 
have unraveled novel knowledge about biochemical and 
physiological processes in virus, bacteria, and parasite 
infections [17–19], which could guide the identification 
of diagnostic biomarkers. To the best of our knowledge, 
metabolomics tools have not been employed to study the 
host responses to M. hyopneumoniae infection. In order 
to identify the metabolic changes associated with an early 
M. hyopneumoniae infection, our current study charac-
terized the metabolic differences between infected and 
uninfected pigs through metabolomics analysis.
Materials and methods
Chemicals and reagents
Amino acid standards, α-aminobutyric acid, n-butanol, 
and sodium pyruvate were purchased from Sigma-
Aldrich (St. Louis, MO, USA), LC–MS-grade water, 
acetonitrile (ACN), and formic acid were obtained from 
Fisher Scientific (Houston, TX, USA), 2,2′-dipyridyl 
disulfide (DPDS) was obtained from MP Biomedicals 
(Santa Ana, CA, USA), dansyl chloride (DC) was pur-
chased from Acros Organics (Morris Plains, NJ, USA), 
2-hydrazinoquinoline (HQ) and triphenylphosphine 
(TPP) were obtained from Alfa Aesar (Haverhill, MA, 
USA), and p-chlorophenylalanine was purchased from 
Alexis Biochemicals (San Diego, CA, USA).
Experimental design
Samples for metabolomics analysis were obtained from 
12 randomly-selected pigs that were either mock inocu-
lated controls or inoculated with M. hyopneumoniae 
in an experimental study previously conducted by our 
research group [13]. At 0  dpi, 2 mock inoculated con-
trols were intra-tracheally inoculated with 10  mL of 
sterile modified Friis medium [20], whereas the remain-
ing 10 pigs were intra-tracheally inoculated with 10 mL 
of a lung homogenate containing 1 × 105 CCU/mL of M. 
hyopneumoniae strain 232 [21]. Serum samples, laryngeal 
swabs (LS), and tracheobronchial lavage fluid (TBLF) 
collected on 0, 2, 5, 9, 14, 21 and 28  dpi were used for 
the analysis in the present study. At 28 dpi all pigs were 
euthanized, bronchial swabs (BS) were collected, and the 
level of lung lesions observed in each lobe were recorded 
in percentage (0 to 100%) as previously described [22].
Detection of M. hyopneumoniae genetic material
Laryngeal swabs, TBLF, and BS samples were examined 
by a M. hyopneumoniae species specific real-time PCR 
[12]. Genomic DNA was extracted from samples using 
the DNeasy Blood and Tissue Kit (Qiagen, Valencia, CA, 
USA). Real-time PCR was performed using M. hyopneu-
moniae specific reagents and controls (VetMAX™, Life 
Technologies Corporation, Carlsbad, CA, USA). Samples 
were considered positive for detection of M. hyopneumo-
niae when the Ct value was < 37.
Metabolomics analysis
Serum samples were analyzed using a liquid chromatog-
raphy–mass spectroscopy (LC–MS) based metabolomics 
platform, which included serum sample preparation, 
chemical derivatization, data deconvolution process-
ing, and multivariate analysis (MDA) followed by marker 
characterization and quantification [23].
Sample preparation
For detecting metabolites containing amino functional 
groups in their structure, samples were derivatized 
with DC prior to the LC–MS analysis. Briefly, 5  μL of 
serum or standard was mixed with 5  μL of 50  μmol/L 
 d5-tryptophan (internal standard), 50  μL of 10  mmol/L 
sodium carbonate, and 100  μL of DC solution (3  mg/
mL in acetone). The mixture was incubated at 60  °C for 
15 min and centrifuged at 21 000 × g for 10 min, and the 
supernatant was transferred into a sample vial for LC–MS 
analysis. Additionally, to detect carboxylic acids, alde-
hydes, and ketones, samples were derivatized separately 
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with HQ prior to the LC–MS analysis [24]. For HQ reac-
tions, 2 μL of sample was added into a 100 μL of freshly 
prepared ACN solution containing 1 mM DPDS, 1 mM 
TPP, and 1 mM HQ. The reaction mixture was incubated 
at 60 °C for 30 min and then chilled on ice immediately. 
After centrifugation at 21 000 × g for 10 min, the super-
natant was transferred into a high-performance liquid 
chromatography (HPLC) vial for LC–MS analysis.
Figure 1 Detection of Mycoplasma hyopneumoniae genetic material in laryngeal swabs and tracheobronchial lavage fluid. A 
Percentage of pigs detected M. hyopneumoniae-positive in laryngeal swabs (LS) and tracheobronchial lavage fluid (TBLF) by real-time PCR. 
The LS and TBLF were obtained on seven samplings during the 28-day period following experimental inoculation with M. hyopneumoniae. The 
percentage of pigs detected positive for M. hyopneumoniae in TBLF was significantly higher at 14 and 21 dpi (p < 0.05). B Individual Ct values and 
mean from PCR detection of M. hyopneumoniae in TBLF samples from 10 inoculated pigs at different days post-inoculation. The Ct values of M. 
hyopneumoniae-negative samples were presented as 40, which is the arbitrary threshold value of M. hyopneumoniae PCR detection.
Page 4 of 10Surendran Nair et al. Vet Res           (2019) 50:98 
LC–MS analysis
A 5 μL aliquot of each sample was injected into an ultrap-
erformance liquid chromatography–quadrupole time-
of-flight mass spectrometry (UPLC–QTOFMS) system 
(Waters Corporation, Milford, MA, USA) and separated by 
a BEH C18 column (Waters Corporation) with a gradient 
of mobile phase ranging from water to 95% aqueous ACN 
containing 0.1% formic acid over a 10-min run. Capillary 
voltage and cone voltage for electrospray ionization were 
maintained at 3 kV and 30 V for positive mode detection, 
whereas source temperature and desolvation temperature 
were set at 120 and 350 °C, respectively. Nitrogen was used 
as both cone gas (50 L/h) and desolvation gas (600 L/h), 
and argon was used as collision gas. For accurate mass 
measurement, the mass spectrometer was calibrated with 
sodium formate solution (range m/z 50 to 1000) and moni-
tored by the intermittent injection of the lock mass leucine 
enkephalin ([M+H]+ = 556.2771  m/z) in real time. Mass 
chromatograms and mass spectral data were acquired and 
processed by MassLynx software (Waters Corporation) in 
centroided format. Additional structural information was 
obtained by tandem MS (MS/MS) fragmentation with col-
lision energies ranging from 15 to 40 eV [25].
Marker identification and characterization
The chromatographic and spectral data of samples from 
the UPLC–QTOFMS system were deconvoluted using 
MarkerLynx software (Waters Corporation). MarkerLynx 
provided a multivariate data matrix containing informa-
tion on sample identity, ion identity (retention time and 
m/z), and ion abundance. The abundance of each ion 
was calculated by normalizing the single ion counts to 
the total ion counts in the entire chromatogram, and the 
data matrix was then exported into SIMCA-P+ software 
(Umetrics, Kinnelon, NJ, USA). Principal components 
analysis (PCA) was used to model the data for the mock 
inoculated controls and inoculated groups. Metabolite 
markers were identified by analyzing ions contributing 
to sample separation in PCA models. QuanLynx soft-
ware (Waters Corporation) was used for the quantifica-
tion of metabolites, and standard curves were generated 
by incorporating amino acid and fatty acid standard mol-
ecules in the LC–MS run. The concentrations or relative 
abundances of identified metabolite markers in the sam-
ples and correlations among these metabolite markers 
were evaluated using GraphPad and R program [26].
Figure 2 Effects of Mycoplasma hyopneumoniae infection in serum metabolome. Data from LC–MS analysis of serum samples were processed 
by principal component analysis (PCA). A Score plot of PCA model. Serum samples collected at 0, 2, 5, 9 dpi were separated from those collected 
at 14, 21, 28 dpi along the 1st principal component of the model (dashed boxes). Additionally, samples from inoculated pigs at 14 and 21 dpi 
were further separated from other samples (circled). B Loading plot of PCA model. Major markers contributing to sample separation (I–XX) in the 
PCA model were identified and labeled in the loading plot and further characterized by structural analysis. The identities of these metabolites are 
presented in Table 1. C Distribution profile of metabolite markers. The heat map from hierarchical cluster analysis classified the metabolite markers 
as time-dependent metabolites and infection-responsive metabolites.
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Statistical analysis
Statistical analysis of metabolomic parameters was per-
formed as a two-tailed Student’s t tests for paired data 
within a time point. Friedman test, the non-parametric 
alternative to the one-way ANOVA with repeated meas-
ures, was used to test for differences among metabolites 
between mock inoculated controls and inoculated pigs 
over time. Hierarchical cluster analysis (HCA) was per-
formed to identify metabolite clusters contributing to 
sample separation. Pearson analysis was performed to 
evaluate the correlation between metabolite markers 
and detection of M. hyopneumoniae in serum samples. 
Differences between the mock inoculated controls and 
inoculated pigs were considered significant if p < 0.05 
and were considered a trend when between 0.05 and 
0.10.
Results
Detection of M. hyopneumoniae genetic material
Real-time PCR analysis of LS, TBLF, and BS confirmed 
that mock inoculated control pigs were negative for M. 
hyopneumoniae throughout the study. Among inoculated 
pigs, M. hyopneumoniae DNA was detected in LS and 
TBLF of all pigs (100%) starting at 9 dpi (Figure 1A). The 
load of M. hyopneumoniae DNA in TBLF peaked at 14 
and 21 dpi and then decreased at 28 dpi (Figure 1B). In 
addition, BS samples of all inoculated pigs at euthanasia 
(28 dpi) were positive for M. hyopneumoniae DNA.
Lung lesions suggestive of M. hyopneumoniae infection
Post-mortem scoring of lung lesions was conducted at 
28 dpi. Lesion scores ranged from 4 to 52% among the 10 
inoculated pigs, with a mean score of 18.3%. No macro-
scopic lung lesions were observed in mock inoculated con-
trol pigs.
Changes in serum metabolome during early M. 
hyopneumoniae infection
The distribution of 84 serum samples from mock inoc-
ulated control and inoculated pigs in a score plot of the 
PCA model on pooled LC–MS data showed that sam-
ples collected at 0, 2, 5, and 9  dpi were clearly sepa-
rated from samples collected at 14, 21, and 28 dpi along 
the 1st principal component of the model (Figure  2A). 
This distribution profile suggests the existence of time-
dependent metabolic changes in both mock inoculated 
control and inoculated pigs. More importantly, the 
majority of serum samples from infected pigs at 14 and 
21 dpi were further separated from other samples in the 
1st principal component of the model, indicating the 
occurrence of infection-responsive metabolic changes 
(Figure  2A). The metabolites contributing to time- and 
Table 1 Identities of top 20 metabolites associated with pig growth and Mycoplasma hyopneumoniae infection 
ID Identity (derivative) m/z of charged ion Formula of original 
molecule
Database
I Oleic acid (HQ) 424.3321+ C18H34O2 HMDB00207
II Linoleic aicd (HQ) 422.3164+ C18H32O2 HMDB00673
III PC(18:0/20:4) 810.6034+ C46H84NO8P HMDB0013420
IV Glycine (DC) 309.0906+ C2H5NO2 HMDB0000123
V Palmitoleic acid 396.3009− C16H30O2 HMDB0003229
VI PC(18:0/18:1) 788.6193+ C44H86NO8P HMDB08069
VII PC(16:0/18:1) 760.5874+ C42H82NO8P HMDB08315
VIII PC(16:0/20:4) 782.5718+ C44H80NO8P HMDB11221
IX Myristic acid (HQ) 370.2851+ C14H28O2 HMDB00806
X Arachidonic acid (HQ) 446.3167+ C20H32O2 HMDB01043
XI LysoPC(16:0) (DC) 496.3405+ C26H42N6O5
XII Tyramine (DC) 371.1428+ C8H11NO HMDB00306
XIII Unknown (HQ) 279.0934+
XIV Alpha aminobutyric acid (DC) 337.1217+ C4H9NO2 HMDB01906
XV LysoPC(18:0) (DC) 522.3562+ C14H36N6 HMDB39491
XVI Unknown (DC) 365.1363+
XVII N2-Acetyl-l-ornithine (DC) 408.1588+ C7H14N2O3 HMDB0003357
XVIII LysoPC(20:4) (HQ) 544.3401+ C20H38O2
X1X PC(O-20:0/21:0) 846.7581+ C50H99O12P
XX PC(18:3/22:5) 836.62+ C48H86NO8P HMDB08056
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infection-dependent sample separation were identi-
fied in a loading plot of the PCA model (Figure 2B), and 
their identities (I–XX) were elucidated as free fatty acids, 
phospholipids, and amino acid metabolites, respectively 
(Table 1).
The correlations between metabolites and samples 
were further characterized by hierarchical clustering 
analysis. Consistent with their distribution profile in the 
PCA model, samples at 0, 2, 5 and 9 dpi and samples at 
14, 21, and 28  dpi formed two major clusters based on 
time (Figure  2C). The metabolites contributing to this 
time-dependent clustering are mainly comprised of 
various phosphatidylcholines (PC) and lyso-phosphati-
dylcholines (lyso-PC; Figure  2C). More importantly, 
A B
DC
E
Figure 3 Concentrations of free fatty acids in serum samples. Concentrations of total and individual free fatty acids (FFA) in mock inoculated 
control and inoculated serum samples were measured. A Total FFA. B Myristic acid. C Palmitoleic acid. D Oleic acid. E Linoleic acid. *p < 0.05.
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multiple free fatty acids and an amino acid metabolites 
were identified as infection-responsive metabolites 
because these metabolites were present in much higher 
abundance in inoculated pig serum compared to mock 
inoculated control serum at 14 and 21 dpi (Figure 2C).
Changes in serum free fatty acids during early M. 
hyopneumoniae infection
The concentrations of total free fatty acids (FFA) and 
individual FFA, including myristic acid, palmitoleic acid, 
oleic acid, and linoleic acid in serum samples were sig-
nificantly elevated at 14 and 21  dpi in inoculated pigs 
(p < 0.05; Figures 3A–E).
Changes in serum amino acids during early M. 
hyopneumoniae infection
Quantitative analysis of free amino acids was conducted 
to determine the status of the serum amino acid pool. 
A significant increase in α-aminobutyric acid (AABA), 
a non-proteinogenic amino acid, was identified at 14 
and 21  dpi in inoculated pigs (p < 0.05; Figure  4). The 
quantified total free amino acids (FAA) in serum were 
comparable at all samplings between mock inoculated 
controls and inoculated pigs (data not shown).
Correlation between metabolite markers and detection 
of M. hyopneumoniae in TBLF
A significant correlation was observed between 
the concentration of AABA detected in serum of 
inoculated pigs and Ct values for M. hyopneumoniae 
detection in TBLF (p < 0.05). A negative correlation was 
indicated based on low Ct values (high bacterial bur-
den and greater correlation with the increased concen-
tration of AABA; Figure 5A). A similar effect was also 
observed with the long chain fatty acid concentrations 
and Ct values (p < 0.05; Figures 5B–E).
Discussion
Mycoplasma hyopneumoniae has been recognized as an 
endemic pathogen globally. The typical lesions of EP have 
been reported to occur in 30 to 80% of slaughter pigs in 
different countries [20]. In the United States alone, par-
ticularly, in large swine operations with more than 5000 
pigs, 28.3% of nursery sites and 57.4% of finisher sites 
have been reported positive for M. hyopneumoniae in a 
survey conducted by the National Animal Health Moni-
toring System [27]. The lack of clear understanding on 
the pathogenesis of M. hyopneumoniae limits current 
efforts to control and manage the clinical disease in the 
field. Furthermore, the mechanisms of immune modu-
lation and the immunopathology associated with EP are 
not fully understood [3]. Hence, there is a growing need 
for practical surveillance tools to complement diag-
nostics to demonstrate early or sub-clinical infections 
in swine populations. In this study, potential candidate 
biomarkers in serum associated with pathophysiological 
events occurring in early M. hyopneumoniae infections 
were identified using state-of-art metabolomics analysis.
The serum metabolomics profile identified both, infec-
tion-dependent and independent changes in experi-
mentally infected pigs. The host metabolic responses 
to M. hyopneumoniae challenge were observed as early 
as 5 dpi. It has been shown that the attachment of bac-
terial cells to tracheal cilia is one of the events preced-
ing M. hyopneumoniae infection and it may occur 5 days 
after experimental challenge [28], when most pigs remain 
asymptomatic [11, 29, 30].
A significant increase in the levels of AABA was iden-
tified at 14 and 21  dpi in this study. AABA is a non-
proteogenic amino acid and often considered to be a 
catabolic product of other amino acids. As shown in 
humans, AABA is biosynthesized by transamination of 
α-ketobutyric acid, a metabolite in branched chain amino 
acids biosynthesis [31]. Alternatively, α-ketobutyric 
acid is decarboxylated to propionate with the forma-
tion of propionyl-CoA and succinyl-CoA, and enters 
the Krebs cycle [32, 33]. Ophthalmic acid is the down-
stream byproduct from AABA and is known to be an 
oxidative stress marker involved in glutathione metabo-
lism [34]. Observing the significant changes in AABA 
Figure 4 Concentration of α-amino butyric acid (AABA) in serum 
samples. Concentrations of α-amino butyric acid in mock inoculated 
control and inoculated serum samples were measured. *p < 0.05.
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levels in inoculated pigs, the abundances of the precursor, 
α-ketobutyric acid and the downstream product, oph-
thalmic acid were also evaluated in this study. However, 
there were no marked changes observed in the concen-
trations of the two metabolites in the serum of inoculated 
pigs compared to the mock inoculated controls.
Several studies have also reported AABA as a meta-
bolic indicator of disease severity in human patients with 
sepsis, as well as multiple organ failure syndrome [35, 
36]. Increases in AABA have been suggested to be caused 
by protein hypercatabolism with enhanced intravascu-
lar release of endogenous amino acids to circulation and 
Figure 5 Correlation between metabolite markers and detection of Mycoplasma hyopneumoniae in TBLF. A Alpha-amino butyric acid 
concentrations were strongly correlated with M. hyopneumoniae PCR detection patterns in TBLF (r = −0.57; p < 0.05). B Long chain fatty acid 
concentrations were strongly correlated with M. hyopneumoniae PCR detection patterns in TBLF (r ≥ 0.5; p < 0.05).
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liver dysfunction. Conversely, the role of AABA in infec-
tious disease metabolism in swine has not been deter-
mined in detail yet.
The levels of FFA in serum samples were elevated 
at 14 and 21  dpi in inoculated pigs. This observation is 
consistent with the reported lipolytic activity of myco-
plasmas [37]. The p65 of M. hyopneumoniae is a surface 
lipoprotein which has recently been identified to exhibit 
lipolytic activity with affinity to a wide range of fatty acid 
esters. Schmidt et  al. speculated that the lipolytic func-
tion of p65 could be the reason of the reduced function 
of surfactants in pneumonic pig lungs [37]. Pulmonary 
surfactants are surface-active complex mixtures consist-
ing of phospholipids, neutral lipids, and specific pro-
teins. Surfactants are essential for normal lung function 
by reducing surface tension at pulmonary air–liquid 
interfaces in animals and humans [38, 39]. Among sur-
factant phospholipids, dipalmitoyl phosphatidylcholine 
is reported to be the principal component that reduces 
minimal surface tension at end-expiration [40]. Genome 
scale modelling studies have revealed surfactant degra-
dation and myo-inositol catabolism as critical traits for 
virulence in M. hyopneumoniae [41].
The nutritional requirement of Mycoplasma organ-
isms for fatty acids is well known since their discovery. 
The fastidious nature of mycoplasmas in vitro is defined 
by the requirement of a exogenous supply of amino acids 
and fatty acids in their growth medium [39]. A majority 
of Mycoplasma species including M. hyopneumoniae, 
lack the genes involved in fatty acid synthesis and there-
fore, the building units for bacterial membrane lipids 
are obtained from long chain saturated and unsaturated 
fatty acids present in the host [8]. Fatty acid analyses 
have revealed that Cl6–Cl8 fatty acids account for 79% of 
the M. hyopneumoniae membrane lipid composition, of 
which oleic, as well as palmitic acids are the major fatty 
acids [41]. Recently, metabolic modelling studies have 
suggested that an exogenous supply of fatty acids such as 
palmitic, stearic, oleic and linoleic acids could improve 
the proliferation and survival of M. hyopneumoniae both 
in vitro and in vivo [39].
The present study identified significant changes in 
the host amino acid and fatty acid profiles during early 
stages of M. hyopneumoniae infection. The require-
ment of fatty acids by the pathogen was justified by the 
observed increased abundance of long chain fatty acids 
in the serum. The increased levels of AABA along with 
altered kinetics of amino acids may indicate protein 
hyper-catabolism in hosts. It is also important to note 
that the host metabolic signature in response to M. hyo-
pneumoniae infection reflected the active metabolic 
pattern of the pathogen, rather than that of the defense 
mechanisms. Thus, through characterizing the metabolic 
signature of M. hyopneumoniae infection in pigs, the 
study examined the metabolic responses to early dis-
ease which was sparsely reported before. The informa-
tion procured would aid to improve the capabilities to 
diagnose, control, and eradicate this bacterium from 
swine herds. Nevertheless, the changes observed in the 
experimental inoculation need to be further validated in 
the natural course of infection. Moreover, the molecular 
mechanisms involved in host responses to M. hyopneu-
moniae infection need to be deciphered.
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